
Colorectal Cancer
Latest News

Focusing On Optimal Settings for Selective Internal Radiation Therapy in CRC With Liver Mets
Latest Videos

More News




A 75-Year-Old Man With Right-Sided mCRC




KRAS-Mutated Metastatic CRC

A small subset of patients with colorectal cancer benefited from the combination of nivolumab (Opdivo) and pixatimod (PG545), according to early results from a phase Ib trial.

Pashtoon M. Kasi, MD, MBBS, MS, provides an overview of the potential for liquid biopsies in CRC and advances being made in the treatment landscape. <br />

Raymond Wadlow, MD, discusses the results for the randomized phase II CCTG CO.26 trial investigating the use of immunotherapy versus best supportive care in heavily pretreated patients with colorectal cancer.

Axel Grothey, MD, discussed the results from a safety lead-in cohort to the BEACON CRC trial and highlighted the significance of these data.










































